MEAKSS, a synthetic peptide, is emerging as a promising treatment for neurodegenerative disorders. Derived from the ACTH 4-10 fragment, MEAKSS demonstrates significant regenerative effects by modulating key cellular pathways involved in neuronal survival. Studies suggest that MEAKSS can enhance synaptogenesis, {reduceoxidative stress, and improve c